• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Micro Interventional Devices

The top 10 catheter innovations of 2021

January 31, 2022 By Danielle Kirsh

Last year was a big year for catheter innovation as medtech companies large and small received regulatory approvals for devices ranging from TAVR to single-use endoscopes. Catheter innovations weren’t limited to just adults; Catheter-deployed devices for premature babies and toddlers were also approved and released. And catheter-based devices made up nearly half of last year’s Prix […]

Filed Under: Cardiovascular, Catheters, Endoscopic, Featured, Implants, News Well, Pediatrics Tagged With: Abbott, Boston Scientific, Cardiovascular Systems, EndoFresh, Medtronic, Micro Interventional Devices, Olympus, Preceptis Medical, Stryker, University of California at San Diego

Micro Interventional Devices tricuspid annuloplasty system wins FDA breakthrough device designation

May 27, 2021 By Danielle Kirsh

Micro Interventional Devices today said it received FDA breakthrough device designation for its MIA-T percutaneous tricuspid annuloplasty system. The MIA-T system treats moderate to severe tricuspid regurgitation through a 12F catheter-based system. Get the full story on our sister site, Medical Tubing + Extrusion.

Filed Under: Cardiovascular, Catheters, Structural Heart Tagged With: Micro Interventional Devices

Catheter OEM Oscor gets in on $20m Series D for Micro Interventional Devices

March 7, 2019 By Brad Perriello

Micro Interventional Devices said today that contract manufacturer Oscor led its $20 million Series D round and inked an OEM deal. Newtown, Pa.-based MID said the deal involves a non-exclusive license for Palm Harbor, Fla.-based Oscor’s catheter technology, in return for Oscor’s exclusive right to its MID’s Mia device for treating tricuspid and mitral valve […]

Filed Under: Cardiac Implants, Featured, Funding Roundup, Wall Street Beat Tagged With: Micro Interventional Devices, Oscor

Neovasc inks $3m settlement deal with MID, raises $1m

February 20, 2019 By Fink Densford

Neovasc (NSDQ:NVCN) said today that it inked a $3 million settlement agreement with Micro Interventional Devices to resolve undisclosed allegations related to Neovasc’s transcatheter mitral valve replacement technology, including its flagship Tiara device, and added that it has raised approximately $1.2 million. The agreement includes payments totally approximately $3 million to be made by Neovasc to […]

Filed Under: Business/Financial News, Cardiovascular, Legal News Tagged With: Micro Interventional Devices, neovasc

Micro Interventional Devices touts early results in tricuspid repair trial

December 3, 2018 By Sarah Faulkner

Micro Interventional Devices last week touted early results from a study of its minimally invasive annuloplasty technology as a treatment for severe tricuspid regurgitation. The technology has been successfully implanted percutaneously in four patients, the company reported. Get the full story at our sister site, Medical Design & Outsourcing.

Filed Under: Cardiovascular, Clinical Trials Tagged With: Micro Interventional Devices

Micro Interventional Devices begins study of tech for heart valve repair

October 15, 2018 By Nancy Crotti

The first patient in the transcatheter arm of a European study has been treated with Micro Interventional Devices’ MIA technology for tricuspid and mitral repair, the company said. A team at Vilnius University Hospital Santariskiu Clinic (Vilnius, Lithuania) used the 12F MIA (minimally invasive annuloplasty) delivery catheter and PolyCor anchors to reduce tricuspid annular dimensions and […]

Filed Under: Cardiac Implants, Featured, Research & Development Tagged With: Micro Interventional Devices

Micro Interventional Devices touts 2nd valve repair with Mia device trial

March 1, 2017 By Fink Densford

Micro Interventional Devices said today it completed the 2nd successful procedure with its Mia device designed for percutaneous mitral and tricuspid repairs. The Newtown, Penn.-based company’s MIA implant is composed of PolyCor anchors and MyoLast implantable elastomer, and is designed to reduce annular dimensions and regurgitation after being deployed in the patient’s native annulus. “On Friday, February 3rd, […]

Filed Under: Cardiovascular, Clinical Trials Tagged With: Micro Interventional Devices

Micro Interventional Devices launches MIS annuloplasty trial

December 20, 2016 By Fink Densford

Micro Interventional Devices said yesterday it completed the 1st clinical implantation of its MIA implant in the STTAR clinical trial of the device, which is designed for minimally invasive mitral and tricuspid repair procedures. The Newtown, Penn.-based company’s MIA implant is composed of PolyCor anchors and MyoLast implantable elastomer, and is designed to reduce annular dimensions and […]

Filed Under: Cardiovascular, Clinical Trials Tagged With: Micro Interventional Devices

Micro Interventional Devices wins FDA nod for Permaseal

July 29, 2016 By Fink Densford

Micro Interventional Devices said today it won FDA 510(k) clearance for its Permaseal transapical access and closure device. The Permaseal device is designed to allow surgeons to access and close the left-ventricle without having to suture the myocardium using the companies compliant soft-tissue PolyCor anchor technology. “The FDA market clearance of Permaseal is another tremendous […]

Filed Under: 510(k), Cardiovascular, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Micro Interventional Devices

Micro Interventional wins CE Mark for Permaseal transapical closure device

June 7, 2016 By Fink Densford

Micro Interventional Devices said today it won CE Mark approval in the European Union for its Permaseal transapical closure device. The Permaseal closure device is designed to allow surgeons to access and close the left-ventricle instantaneously without suturing the myocardium, the Newtown, Penn.-based company said. “The CE Mark approval of Permaseal is a tremendous achievement […]

Filed Under: Business/Financial News, Cardiovascular Tagged With: Micro Interventional Devices

Stung by widening losses, Accuray plans $75M debt offering | Wall Street Beat

February 7, 2013 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Accuray (NSDQ:ARAY) plans to issue $75 million worth of convertible senior notes as it gears up to restructure its business after a year of widening losses.

The Sunnyvale, Calif.-based medical device company said it will use the proceeds from the offering of debt due Feb. 1, 2018, to shore up its balance sheet.

Filed Under: Funding Roundup, MassDevice Earnings Roundup, News Well, Radiosurgery/Radiation therapy, Wall Street Beat Tagged With: Accuray Inc., Biosensors International Group Ltd., InspireMD, Micro Interventional Devices, Safeguard Scientifics Inc., Sotera Wireless, Terumo

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy